Well Said | Zucker School Of Medicine

Patients with gastrointestinal (GI) disorders may be at higher risk for COVID-19 complications. Dr. Ira Nash and Northwell Health’s Dr. Arun Swaminath, chief of gastroenterology, director, Inflammatory Bowel Disease, Lenox Hill Hospital, and associate professor of medicine, talk with one of his GI patients and discuss which IBS/GI medications can impact the immune system and why, and how follow-up visits with your gastroenterologist can help to keep you safe and healthy. Resources: https://www.northwell.edu/coronavirus-covid-19 Donning a new approach to the practice of gastroenterology: perspectives from the COVID-19 pandemic epicenter. Management of upper GI bleeding in patients with COVID-19 pneumonia.